Combination of DNA prime--adenovirus boost immunization with entecavir elicits sustained control of chronic hepatitis B in the woodchuck model. - Wikidata - awgldk - TriplyDB

Combination of DNA prime--adenovirus boost immunization with entecavir elicits sustained control of chronic hepatitis B in the woodchuck model.

Combination of DNA prime--adenovirus boost immunization with entecavir elicits sustained control of chronic hepatitis B in the woodchuck model.

http://www.wikidata.org/entity/Q34778476

about

Therapeutic Strategies and New Intervention Points in Chronic Hepatitis Delta Virus Infection Therapeutic vaccination and immunomodulation in the treatment of chronic hepatitis B: preclinical studies in the woodchuck Hepatitis B: future curative strategies Future Therapy for Hepatitis B Virus: Role of Immunomodulators Mutational escape of CD8+ T cell epitopes: implications for prevention and therapy of persistent hepatitis virus infections A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearance.Tapasin modification on the intracellular epitope HBcAg18-27 enhances HBV-specific CTL immune response and inhibits hepatitis B virus replication in vivo.Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection.Immune therapeutic strategies in chronic hepatitis B virus infection: virus or inflammation control?Enhancing virus-specific immunity in vivo by combining therapeutic vaccination and PD-L1 blockade in chronic hepadnaviral infection.Antiviral therapies and prospects for a cure of chronic hepatitis B.Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections.A Toxoplasma gondii vaccine encoding multistage antigens in conjunction with ubiquitin confers protective immunity to BALB/c mice against parasite infection Present and future therapies of hepatitis B: From discovery to cure Prime/boost immunization with DNA and adenoviral vectors protects from hepatitis D virus (HDV) infection after simultaneous infection with HDV and woodchuck hepatitis virus.Medical virology of hepatitis B: how it began and where we are now Novel Woodchuck Hepatitis Virus (WHV) transgene mouse models show sex-dependent WHV replicative activity and development of spontaneous immune responses to WHV proteins.New therapeutic vaccination strategies for the treatment of chronic hepatitis B.Interplay between hepatitis B virus and the innate immune responses: implications for new therapeutic strategies.Treatment options beyond IFNα and NUCs for chronic HBV infection: expectations for tomorrow.Dissecting the dendritic cell controversy in chronic hepatitis B virus infection.Circumventing failed antiviral immunity in chronic hepatitis B virus infection: triggering virus-specific or innate-like T cell response?Therapeutic vaccines in HBV: lessons from HCV.Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure.Immune Response in Hepatitis B Virus Infection.Treatment of chronic hepatitis B with pattern recognition receptor agonists: Current status and potential for a cure Advances in therapeutics for chronic hepatitis B.The Woodchuck, a Nonprimate Model for Immunopathogenesis and Therapeutic Immunomodulation in Chronic Hepatitis B Virus Infection.Prospects and progress of DNA vaccines for treating hepatitis B.Molecular cloning, characterization and expression analysis of woodchuck retinoic acid-inducible gene I.Present and future DNA vaccines for chronic hepatitis B treatment.Treatment of hepatitis B virus: an update.Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection.The IL-1R/TLR signaling pathway is essential for efficient CD8(+) T-cell responses against hepatitis B virus in the hydrodynamic injection mouse model.TLR9-Mediated Conditioning of Liver Environment Is Essential for Successful Intrahepatic Immunotherapy and Effective Memory Recall.Low hepatitis B virus-specific T-cell response in males correlates with high regulatory T-cell numbers in murine models.Functional aspects of intrahepatic hepatitis B virus-specific T cells induced by therapeutic DNA vaccination Enhancement of HCV polytope DNA vaccine efficacy by fusion to an N-terminal fragment of heat shock protein gp96.A meta-analysis of the antiviral activity of the HBV-specific immunotherapeutic TG1050 confirms its value over a wide range of HBsAg levels in a persistent HBV pre-clinical model.Interaction between Hepatitis B Virus and Toll-Like Receptors: Current Status and Potential Therapeutic Use for Chronic Hepatitis B.

P2860

Q26795919-14811E5A-CF9D-42AE-9A9E-90AE7DE26D10 Q26828598-D4F518E3-4814-4D80-8A20-39642C4F7110 Q27011623-189988FC-7CF4-494C-878E-2EFC4218E964 Q28078148-9FF43B70-2110-4D2B-B07E-678477E20026 Q28086907-119E0ECF-823F-4FDE-877E-8B1997B3B1B3 Q33933196-59BD31DC-649B-4EA5-8308-32ECF889D195 Q34409291-B943F7FC-B989-4CBF-BC80-6A31A445BD1E Q35008279-3B4AAF8F-D80B-45E7-BBB4-62839BCD0B1F Q35075107-5B5285AA-11E2-40B6-82BE-ECB03B25294E Q35082215-5BF274F3-5ECB-415C-9A0A-644F0E3120FD Q35245231-E0241753-6446-46C5-BA56-9F160D8DF8C2 Q36073739-2C990280-05B9-4215-A835-6ADFDDB022F4 Q36107127-F0C40C64-B524-4873-A531-E95ED3C9E30E Q36378278-17C57861-374F-47BD-A69B-BBCF12C3E73D Q36978876-0F14F116-A766-4D9B-AE6F-CA5DFA6D18FC Q37059714-6291293E-E4C0-4F6D-A3FC-A3A524D0749E Q37547342-CBC8D64E-16C8-49E2-ADF1-6140971036BB Q38180981-E5F2BF8A-857D-4143-A760-C58C98F30204 Q38180983-93F92B17-A18C-405E-B919-8AFAED08E780 Q38255840-7734C4D8-06B7-4518-A35B-246354D02621 Q38264371-EE092952-DFC9-45AA-8E60-853E1E11360D Q38289729-7B14EA91-3426-4D3A-9A65-284AD0E8AF3E Q38312255-4C0A17F7-D1AE-41E2-AB2E-CFF85B62872A Q38351585-575BC15D-4262-4536-8273-5D6959B3A1A1 Q38541811-F7962BF2-EA19-4AD0-98FE-CC085279F778 Q38553065-5B5E770F-C7BF-45B0-8BD6-B4B8AB3845D6 Q38585657-A8EE2018-1FAE-4A13-B419-7596716E146E Q38618869-A920C9CC-ED5C-4B41-BEB3-5EABEAEA260D Q38664504-10FD30E3-A97F-4FAD-A8F3-B7506CBAF674 Q38759960-8CCB26B4-F73B-4D8F-B6EF-5170D1D43BC4 Q38790065-DE14A1BB-D6D5-46CE-9779-C08FD1969486 Q38794446-3BFEB590-451F-48AC-8E40-CAED4C5DC5AE Q38846017-E547DDDA-E268-4B70-AA75-2C3187159082 Q40102035-B92C9E37-AADC-4CB7-A900-1A6A19BE7FA9 Q40119511-1E5C234B-A6CD-4354-B978-90CE57C1BF53 Q40291593-5D2E18A7-E4DB-4503-9277-8E80E5453DFA Q41607528-7BDF8258-2FE1-4E9F-8ACE-A69288770F66 Q42182831-7D5C720A-1E98-4EA0-9F4D-3711C7CE35B6 Q47547227-8E7E1362-1811-4430-A6BC-523AA4730A15 Q47553095-2A36C27C-8D45-48B2-A024-7FD867EA8AFA

P2860

Combination of DNA prime--adenovirus boost immunization with entecavir elicits sustained control of chronic hepatitis B in the woodchuck model.

http://www.wikidata.org/entity/Q34778476

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Combination of DNA prime--aden ...... itis B in the woodchuck model.

@ast

Combination of DNA prime--aden ...... itis B in the woodchuck model.

@en

Combination of DNA prime--aden ...... itis B in the woodchuck model.

@nl

type

label

Combination of DNA prime--aden ...... itis B in the woodchuck model.

@ast

Combination of DNA prime--aden ...... itis B in the woodchuck model.

@en

Combination of DNA prime--aden ...... itis B in the woodchuck model.

@nl

prefLabel

Combination of DNA prime--aden ...... itis B in the woodchuck model.

@ast

Combination of DNA prime--aden ...... itis B in the woodchuck model.

@en

Combination of DNA prime--aden ...... itis B in the woodchuck model.

@nl

P1433

Q34778476-D4D2F01C-FAA3-479B-B757-D05678A98AD6

P1476

Q34778476-A56E8D39-7A6A-499C-8903-B15CA3439E4A

P2093

Q34778476-02012357-95B4-4EF8-8F56-D048257FA52B

Q34778476-0860D51A-7777-4894-9D02-14E708815384

Q34778476-0FA73335-B45D-487D-B92D-ABED9BBA4745

Q34778476-22412D54-2E4B-4474-9A0B-4C90BCCBE5D1

Q34778476-2E2DA157-D516-4D6B-8923-466B2784BB5A

Q34778476-38E2CBC4-CEAA-4FFC-958D-F5950AA2DB7E

Q34778476-42018083-32D5-4247-8489-3FBB20E7ED75

Q34778476-60950405-D5B6-40D8-AFB4-600356A81A93

Q34778476-870A423C-8EEA-4EE7-BEA0-0482B34EC21E

Q34778476-AA80F516-5F16-4929-B6E4-4C99555FF20B

P2860

Q34778476-04C4F76C-D255-49F8-A3B5-E1011AFCBB55

Q34778476-0637DA64-EDFC-47CB-85A9-6CA83DE29CE0

Q34778476-0816608C-B350-4954-BE61-170CB8465A88

Q34778476-0E450482-FA5F-450B-AEEC-F1B3E925480B

Q34778476-129F1BD5-A4C0-4803-97D1-200B61A9EC90

Q34778476-155AF420-2F87-4D72-9379-B41267D8CCD8

Q34778476-17EF5A02-D2E5-4197-86F4-BB3BB7EAFAFE

Q34778476-1C844A9D-EA62-461B-B2A8-DA2C350C2D82

Q34778476-25D1BF30-721D-4E3D-B3A8-3B7C9CE78DBE

Q34778476-308189D5-E7AC-4EDE-921B-F1D05AC4BCAB

P304

Q34778476-C0015C08-1EC7-4114-A2C6-E359D40F05DA

P31

Q34778476-C30E24E8-266F-44F2-B926-C2A72D30B0A7

P356

Q34778476-83DC758D-9A1F-422B-801F-630273F54022

P433

Q34778476-276AFB66-5999-45AD-BA8E-A3C51D068135

P478

Q34778476-198BE5D8-7809-4FF7-B3CD-541A1747DBC3

P50

Q34778476-CF2B6181-C8DA-4D24-BF02-0A1697AA186A

P577

Q34778476-AE5B3703-7177-4068-90C8-14B0A6A89467

P5875

Q34778476-7A7AF47D-AD9B-44EF-879E-C18AE53377DC

P698

Q34778476-2D0862D6-1840-409C-99E3-7EBC493291E9

P921

Q34778476-75CD39E6-518B-458A-BCDC-A18A4AA47E68

Q34778476-B61B54E7-F8AB-4BAC-8715-D4518C278A88

P932

Q34778476-0DF5D466-9802-430D-BA26-D01D1ACDA0C5

P356

JOURNAL.PPAT.1003391

P1433

P1476

Combination of DNA prime--aden ...... itis B in the woodchuck model.

@en

P2093

Anna D Kosinska

http://www.w3.org/2001/XMLSchema#string

Dieter Glebe

http://www.w3.org/2001/XMLSchema#string

Ejuan Zhang

http://www.w3.org/2001/XMLSchema#string

Jia Liu

http://www.w3.org/2001/XMLSchema#string

Lena Johrden

http://www.w3.org/2001/XMLSchema#string

Melanie Fiedler

http://www.w3.org/2001/XMLSchema#string

Mengji Lu

http://www.w3.org/2001/XMLSchema#string

Michael Roggendorf

http://www.w3.org/2001/XMLSchema#string

Oliver Wildner

http://www.w3.org/2001/XMLSchema#string

Pia L Seiz

http://www.w3.org/2001/XMLSchema#string

P2860

Immunology of hepatitis B virus and hepatitis C virus infection

Regulatory T cells suppress antiviral immune responses and increase viral loads during acute infection with a lymphotropic retrovirus

Immune effectors required for hepatitis B virus clearance

CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection.

DNA prime-adenovirus boost immunization induces a vigorous and multifunctional T-cell response against hepadnaviral proteins in the mouse and woodchuck model.

Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen.

Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver.

The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection

Evidence for long-range oncogene activation by hepadnavirus insertion

Vaccines and immunotherapies against hepatitis B and hepatitis C viruses.

P304

e1003391

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PPAT.1003391

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-06-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

240306900

http://www.w3.org/2001/XMLSchema#string

P698

23785279

http://www.w3.org/2001/XMLSchema#string

P921

P932

3681757

http://www.w3.org/2001/XMLSchema#string